Published: Dec. 14, 2020, 5 p.m.
Today's episode is about the management of tardive dyskinesia.
Here are some questions we cover in this episode:
- What is the best way to approach tardive dyskinesia? This episode will discuss an algorithm with levels of evidence for each treatment option.
- What is the evidence level for second-generation VMAT-2 inhibitors, such as deutetrabenazine and valbenazine?
- Is there evidence for prescribing anticholinergics in tardive dyskinesia? Should you use them?
- What options do you have if a VMAT inhibitor is not effective or well tolerated?
Faculty: Greg Pontone, M.D.